Benchlight The federal appellate judiciary

This writing

Type
Opinion
Author
Alan David Lourie
Filed
June 25, 2024
Case
Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc.
Case status
Decided

Source The authoring judge was read from the signature line of the court's own published opinion.

Opening text

The first passage of the document, as extracted by the source provider.

Case: 23-1169 Document: 43 Page: 1 Filed: 06/25/2024 United States Court of Appeals for the Federal Circuit ______________________ AMARIN PHARMA, INC., AMARIN PHARMACEUTICALS IRELAND LIMITED, MOCHIDA PHARMACEUTICAL CO., LTD., Plaintiffs-Appellants v. HIKMA PHARMACEUTICALS USA INC., HIKMA PHARMACEUTICALS PLC, Defendants-Appellees HEALTH NET LLC,…

Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.

Read the full document (court PDF)